id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0506-0002,FDA,FDA-2001-D-0506,Draft Guidance for Industry on Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines; Guidance Document,Other,Guidance,2001-03-09T05:00:00Z,2001,3,,,2024-11-07T21:53:22Z,,1,0,09000064804ef97f